Market revenue in 2023 | USD 54.3 million |
Market revenue in 2030 | USD 143.1 million |
Growth rate | 14.9% (CAGR from 2023 to 2030) |
Largest segment | Hydrogels |
Fastest growing segment | Micropatterned Surface Microplates |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Tecan Group AG, Becton Dickinson & Co, Medtronic PLC, Matricelf Ltd, Corning Inc, Avacta Group PLC, Vericel Corp, NuVasive, Allergan, ReproCELL, 3D Biotek, Xanofi, Molecular Matrix, Pelo Biotech, Azenta Life Sciences, Akron Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to scaffold technology market will help companies and investors design strategic landscapes.
Hydrogels was the largest segment with a revenue share of 41.44% in 2023. Horizon Databook has segmented the Brazil scaffold technology market based on hydrogels, polymeric scaffolds, micropatterned surface microplates, nanofiber based scaffolds covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil dominated Latin America scaffold technology market accounting with a revenue share of more than 40% in 2020. The successful development of regenerative medicine in Brail, with a considerable amount of healthcare funding, supports the development of regenerative medicine, subsequently boosting the use of scaffold technology.
The country aims to initiate more studies and foster Brazilian stem cell projects. In 2016, Brazil had 27 stem cell studies in clinical trials. It concentrates on niche areas in regenerative medicines, such as neurology, orthopedics, and cardiology, thereby allowing involved entities to build domestic expertise and initiate developments in clinical applications.
In addition, the policymakers in the country have redesigned innovation laws to encourage ties between researchers and the industry. As reported in January 2019, the country laid down a regulatory path for advanced therapies in line with the regulatory framework of Anvisa.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil scaffold technology market , including forecasts for subscribers. This country databook contains high-level insights into Brazil scaffold technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account